2022 Program

All sessions will be held in the Millbrook Conference Centre.

 

0830 - 0840

Introduction and Welcome

0840 - 1015

Moving the goalposts in ACHD intervention 

0840 - 0900

What can TAVR bring to ACHD   Jonathon White 

0900 - 0920

Rehabilitation of the RVOT, Eric Horlick

0920 - 0940

Atrioventricular valves – what can the interventionalist offer in 2022, Will Wilson 

0940 - 1000

Arch intervention Clare O’Donnell     

1000 - 1015

Panel Discussion

1015 - 1045

Morning Tea
Exhibition Hall, The Pavilion

1045 - 1210

Quality and Outcomes 

1045 - 1105

Risk stratification and Scoring systems – role in clinical practice, Tara Karamlou 

1105 - 1125

How to talk to patients about high risk procedures, Ajay Iyengar 

1125 - 1145

Equity and disparity in cardiology care, Luke Burchill 

1145 - 1205

Bringing guideline directed care to prime time in ACHD: the role of the senior ACHD nurse, Jane Hannah 

1215 - 1310

Lunch 

Exhibition Hall, The Pavilion

1310 - 1500

Interventional keynote address + Fontan updates from the registry and elsewhere 

1310 - 1340

Fontan intervention and other stories - thoughts on evidence based intervention with a relative dearth of evidence, Eric Horlick

1340 - 1400

Long-term outcomes in low-risk patients, Rachael Cordina 

1400 - 1420 

Mental health in Fontan adults, Nadine Kasparian

1420 - 1440

Monitoring for complications: what investigations should I do?, Dominica Zentner 

1440 - 1500

Transplantation for Fontans, Tara Karamlou 

1500 - 1530

Afternoon Tea
Exhibition Hall, The Pavilion

1530 - 1700

Keynote address and research presentations 

1530 - 1600

Keynote Address: ACHD patients across the lifespan: the importance of early surgery, ongoing empiric surveillance, and transition care, Tara Karamlou 

1600 - 1615

Research Presentation: Emerging Diagnostic Strategies in Pulmonary Valve Endocarditis- Amber Khanna

1615 - 1630

Research Presentation: Pattern and Predictors of Loss to Follow-Up in People Living with a Fontan Circulation in Australia and New Zealand- Jacob Cao

1630 - 1645

Research Presentation: Humanitarian crises- a new perspective on lapses in ACHD care- Cheryl Dickson

1645 - 1700

Research Presentation 4

1700 - 1830

Welcome Function

Exhibition Hall, The Pavilion

 

0730 - 0830

Breakfast Session
Sponsored by W.L. Gore

0845 - 1005

Atrial septal defect: the wolf in sheep’s clothing 

0845 - 0905

Closing holes and tunnels- ASDs and beyond, Peter Ruygrok 

0905 - 0925

Older surgical techniques for ASD closure – what to look out for, TBC     

0925 - 0945

Pulmonary hypertension and diastolic dysfunction, David Celermajer 

0945 - 1005

Arrhythmia management, Mark McGuire 

1005 - 1035

Morning Tea
Exhibition Hall, The Pavilion

1035 - 1200

Hypoplastic left heart syndrome 

1035 - 1055

The paediatric background, Tom Gentles 

1055 - 1115

Long-term outcomes, Julian Ayer 

1115 - 1135

Coronary issues and myocardial fibrosis in the systemic right ventricle, Tim Hornung 

1135 - 1155

Neurological outcomes and learning difficulties: HLHS and Fontans, Charlotte Verrall 

1155 - 1250

Lunch
Exhibition Hall, The Pavilion

1250 - 1410

Transposition: late outcomes and long-term issues 

1250 - 1310

Arterial switch 1: Coronary artery and left ventricular function, Michael Cheung 

1310 - 1330

Arterial switch 2: Aortic valve and root re-intervention after the arterial switch operation, Kirsten Finucane 

1330 -1350 

Rastelli: Optimising long-term outcomes – what to look out for, Leeanne Grigg 

1350 - 1410

Atrial baffle repairs: ICDs and resychronisation, Andrew Martin  

1410 - 1440

Afternoon Tea
Exhibition Hall, The Pavilion

1440

Free Time

1830 - Late

Gala Dinner 

 

 

0830 - 1000

Difficult cases 

0830 - 0845

Case Presentation- TV Liew

0850 - 0905

Case Presentation- Vishva Wijesekera

0910 - 0925

Case Presentation- John Lainchbury

0930 - 0945

 Case Presentation- Jelena Saundankar

0945 - 1000

 Case Presentation- TBC

1000 - 1030

Morning Tea
Exhibition Hall

1030 - 1210

Headline News: What’s hot? 

1030 - 1050

Newer medications and their use in ACHD:  NOACs, David Tanous 

1050 - 1110

Newer medications and their use in ACHD:  ARNIs and SGLT2 inhibitors, Mugur Nicolae 

1110 - 1130

Covid and ACHD, David Baker 

1130 - 1150

Update on tetralogy risk stratification, Luciana Marcondes 

1150 - 1210

The latest on Fontan Associated Liver Disease, Kathryn Rice

1205 - 1300

Lunch 
Exhibition Hall

1300 - 1430

The Great Debate 

1300 - 1315

Chaanz update, Rachael Cordina 

1315 - 1330

The ACHD.NZ website, Tim Hornung

1330 - 1345 

ACHD Training discussion, TBC

1345 - 1430 

The Great Debate, Eric Horlick & Will Wilson

 

ACHD 2022 Symposium